Joslin Diabetes Center to Use Metabolon Profiling Technology in Studies | GenomeWeb
NEW YORK (GenomeWeb News) – The Joslin Diabetes Center will use Metabolon’s biochemical profiling technology in human clinical and animal studies of insulin resistance and type 2 diabetes, Metabolon said today.
Research Triangle Park, NC-based Metabolon also will assess the translatability of its human insulin resistance biomarkers when conducting the Joslin diabetic animal model studies. In addition, the partners will collaborate on further validation studies of human biochemical markers of insulin resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.